| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -2,555 | -2,491 |
| Purchase of property and equipment | 1,156 | 138 |
| Net cash used in investing activities | -1,156 | -138 |
| Payment of contingent consideration | 0 | 0 |
| Sale of common stock, net of offering costs | 2,192 | - |
| Net cash provided by financing activities | 2,192 | 0 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -1,519 | -2,629 |
| Cash and cash equivalents at beginning of period | 8,595 | - |
| Cash and cash equivalents at end of period | 7,076 | - |
STRATA Skin Sciences, Inc. (SSKN)
STRATA Skin Sciences, Inc. (SSKN)